Clinical Trial Update: Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 pilot study comparing outcomes of performance status 2 vs 0-1 in non-small cell lung cancer patients treated with chemotherapy and immunotherapy; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Nonsmall Cell Lung Cancer, Performance Status | Phase 2 | Status: RECRUITING